Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Ruffo Frank
Chief Financial Officer at Aclaris Therapeutics. Filing since 6 Apr 2018.
CIK 0001654450
Company
Date
Role
Action
Shares
Amount
Of holding
ACRS
Aclaris Therapeutics, Inc.
10 Mar 2022
Chief Financial Officer
Sold, plan not stated
12,823
$199.33K
6.0%
ACRS
Aclaris Therapeutics, Inc.
9 Feb 2022
Chief Financial Officer
Sold, plan not stated
1,388
$17.57K
0.8%
ACRS
Aclaris Therapeutics, Inc.
2 Jun 2021
Chief Financial Officer
Sold, plan not stated
15,037
$325.38K
8.1%
ACRS
Aclaris Therapeutics, Inc.
26 Apr 2021
Chief Financial Officer
Sold, plan not stated
27,339
$705.23K
15.3%
ACRS
Aclaris Therapeutics, Inc.
23 Apr 2021
Chief Financial Officer
Sold, plan not stated
30,000
$799.66K
14.4%
ACRS
Aclaris Therapeutics, Inc.
22 Apr 2021
Chief Financial Officer
Sold, plan not stated
30,000
$805.22K
12.5%
ACRS
Aclaris Therapeutics, Inc.
7 May 2018
Chief Financial Officer
Bought
1,250
$22.78K
0.8%
ACRS
Aclaris Therapeutics, Inc.
6 Apr 2018
Chief Financial Officer
Bought
1,250
$20.74K
0.8%
8 decisions on file.
